AbstractObjectivesMajor depressive disorder (MDD) is a major public health concern associated with a high burden to society, the health-care system, and patients and an estimated cost of €3.5 billion in Sweden. The objective of this study was to assess the cost-effectiveness of escitalopram versus generic venlafaxine extended-release (XR) in MDD, accounting for the full clinical profile of each, adopting the Swedish societal perspective, and identifying major cost drivers.MethodsCost-effectiveness of escitalopram versus venlafaxine XR was analyzed over a 6-month time frame, on the basis of a decision tree, for patients with MDD seeking primary care treatment in Sweden. Effectiveness outcomes for the model were quality-adjusted life-years an...
Abstract Background Knowledge regarding the relative cost-effectiveness of different antidepressants...
To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmacological fi...
The Author(s) 2014. This article is published with open access at Springerlink.com Objective The obj...
AbstractObjectivesMajor depressive disorder (MDD) is a major public health concern associated with a...
The objective of this study was to assess the cost effectiveness of commonly used antidepressants as...
Objective: This study assessed the cost-effectiveness of escitalopram for the treatment of depressio...
AbstractMethodsWe conducted a multinational pharmacoeconomic evaluation comparing the immediate rele...
Background Depressive disorders place a great burden on society and rank as the fourth leading cause...
Claudio Mencacci,1 Guido Di Sciascio,2 Pablo Katz,3 Claudio Ripellino31Ospedale Fatebenefratelli, Mi...
Kulp W, Hemels M, Greiner W, von der Schulenburg J. Cost-effectiveness analysis of escitalopram in t...
Introduction: Major depressive disorder (MDD) is a common and disabling condition across the world. ...
OBJECTIVE: To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmac...
<div><p>ABSTRACT</p><p><b><i>Objective</i></b>: To assess the cost-effectiveness of vortioxetine <i>...
Objective: To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmac...
AIM: Major depressive disorder is considered one of the most frequent diseases in the general popula...
Abstract Background Knowledge regarding the relative cost-effectiveness of different antidepressants...
To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmacological fi...
The Author(s) 2014. This article is published with open access at Springerlink.com Objective The obj...
AbstractObjectivesMajor depressive disorder (MDD) is a major public health concern associated with a...
The objective of this study was to assess the cost effectiveness of commonly used antidepressants as...
Objective: This study assessed the cost-effectiveness of escitalopram for the treatment of depressio...
AbstractMethodsWe conducted a multinational pharmacoeconomic evaluation comparing the immediate rele...
Background Depressive disorders place a great burden on society and rank as the fourth leading cause...
Claudio Mencacci,1 Guido Di Sciascio,2 Pablo Katz,3 Claudio Ripellino31Ospedale Fatebenefratelli, Mi...
Kulp W, Hemels M, Greiner W, von der Schulenburg J. Cost-effectiveness analysis of escitalopram in t...
Introduction: Major depressive disorder (MDD) is a common and disabling condition across the world. ...
OBJECTIVE: To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmac...
<div><p>ABSTRACT</p><p><b><i>Objective</i></b>: To assess the cost-effectiveness of vortioxetine <i>...
Objective: To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmac...
AIM: Major depressive disorder is considered one of the most frequent diseases in the general popula...
Abstract Background Knowledge regarding the relative cost-effectiveness of different antidepressants...
To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmacological fi...
The Author(s) 2014. This article is published with open access at Springerlink.com Objective The obj...